Drugs / Titanoreine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01881282 | Dec 2006 → Feb 2008 | hemorrhoid | Xian-Janssen Pharmaceutical Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Titanoreine | “Participants will be randomly assigned to either of the two treatment groups that are carraghenates cream (Titanoreine) group or Mayinglong musk hemorrhoid ointment group.” NCT01881282 ↗ |
| Known as | Carraghenates Cream | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01881282 ↗ |
| Route | Other | “through anal canal” NCT01881282 ↗ |